Skip to main content
Caplight Logo









Exobiosphere

Exobiosphere

Private
Esch-sur-AlzetteHealthcare & Life Scienceshttps://exobiosphere.com

Last Round

VC Round

Apr 1, 2026

Total Funding Raised

$3.61M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Exobiosphere operates in Healthcare & Life Sciences and is based in Esch-sur-Alzette. Its latest recorded funding round was a VC Round in April 2026.

Exobiosphere is a biotechnology company that develops automated, space-based high-throughput screening platforms to accelerate drug discovery and preclinical research in microgravity.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Space Technology, Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Exobiosphere Comparables

Compare Exobiosphere with similar companies based on industry and business-model similarity.

Exobiosphere comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SpacePharma
84%
Helogen Corporation
83%
Space LiinTech
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Exobiosphere Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 1, 2026
SeedNov 3, 2025
SeedApr 4, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Kyle Acierno

CEO & Co-Founder

Founding Team

For institutional investors. Book with your work email.

Exobiosphere Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 2, 2026

    Open roles increased to 15, 54% of headcount.

  • Aug 30, 2026

    Grew 38% QoQ, from 21 to 29 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • launchesSep 24, 2026

    Exobiosphere's Orbital High-Throughput Screening in Microgravity (OHTS) platform, a mid-deck-locker-class system for automated drug screening, is scheduled for installation aboard the ISS in Apr '27.

  • receives_financingAug 12, 2026

    Exobiosphere receives $1.15M in non-dilutive government financing through Luxembourg’s Jeune Entreprise Innovante program in Aug '26 to support commercial expansion, team growth, and scaling its automated biomedical experiments platform under microgravity.

  • receives_financingAug 11, 2026

    Exobiosphere receives $1.16M in non-dilutive funding through Luxembourg’s Jeune Entreprise Innovante aid scheme on Aug 11th '26 to support commercial expansion, operations, and the scale-up of its orbital high-throughput screening platform.

Book a demo to see all news

For institutional investors. Book with your work email.

Exobiosphere Filings

Explore SEC and related filing metadata, where available.

Exobiosphere filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Exobiosphere's valuation, stock price, and market status.

Is Exobiosphere a public or private company?

Exobiosphere is a private company.

What is the current stock price of Exobiosphere?

Exobiosphere is a private company, so its shares have no public market price. Caplight tracks Exobiosphere's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Exobiosphere worth (valuation)?

Valuation information for Exobiosphere is not publicly available.

Can I buy Exobiosphere stock?

Exobiosphere shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Exobiosphere's last funding round?

Exobiosphere's most recent funding round was VC Round on April 1, 2026.

Who are the main investors in Exobiosphere?

Key investors in Exobiosphere include Expansion Ventures, Cedars-Sinai Intellectual Property Company.

Will Exobiosphere IPO soon?

No public IPO plans have been announced for Exobiosphere.

How can I track Exobiosphere secondary market activity?

Caplight tracks bids, offers, and trades in Exobiosphere's shares on secondary markets.

Firmographic Details

HeadquartersEsch-sur-Alzette
Employee Range24
Year Founded2024
Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?